关注
Ulrike Köhl
Ulrike Köhl
Universität Leipzig; Fraunhofer-Gesellschaft; Medizinische Hochschule Hannover
在 izi.fraunhofer.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott, M Schmidt, K Schwarzwaelder, S Stein, U Siler, U Koehl, H Glimm, ...
Nature medicine 12 (4), 401-409, 2006
13912006
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
S Stein, MG Ott, S Schultze-Strasser, A Jauch, B Burwinkel, A Kinner, ...
Nature medicine 16 (2), 198-204, 2010
9142010
New insights to the MLL recombinome of acute leukemias
C Meyer, E Kowarz, J Hofmann, A Renneville, J Zuna, J Trka, ...
Leukemia 23 (8), 1490-1499, 2009
5162009
Treatment of patients with advanced cancer with the natural killer cell line NK-92
T Tonn, D Schwabe, HG Klingemann, S Becker, R Esser, U Koehl, ...
Cytotherapy 15 (12), 1563-1570, 2013
4762013
Cochlear implant–state of the art
T Lenarz
Laryngo-rhino-otologie 96 (S 01), S123-S151, 2017
3502017
Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor
K Schönfeld, C Sahm, C Zhang, S Naundorf, C Brendel, M Odendahl, ...
Molecular therapy 23 (2), 330-338, 2015
3432015
The MLL recombinome of acute leukemias
C Meyer, B Schneider, S Jakob, S Strehl, A Attarbaschi, S Schnittger, ...
Leukemia 20 (5), 777-784, 2006
2832006
Advantages and applications of CAR-expressing natural killer cells
W Glienke, R Esser, C Priesner, JD Suerth, A Schambach, WS Wels, ...
Frontiers in pharmacology 6, 21, 2015
2742015
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow …
I Yakoub-Agha, C Chabannon, P Bader, GW Basak, H Bonig, F Ciceri, ...
haematologica 105 (2), 297, 2020
2712020
Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy
K Sasaki, C Heeschen, A Aicher, T Ziebart, J Honold, C Urbich, L Rossig, ...
Proceedings of the National Academy of Sciences 103 (39), 14537-14541, 2006
2632006
111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model
W Brenner, A Aicher, T Eckey, S Massoudi, M Zuhayra, U Koehl, ...
Journal of Nuclear Medicine 45 (3), 512-518, 2004
2632004
Targeted cell entry of lentiviral vectors
S Funke, A Maisner, MD Mühlebach, U Koehl, M Grez, R Cattaneo, ...
Molecular Therapy 16 (8), 1427-1436, 2008
2572008
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties
S Kuçi, Z Kuçi, H Kreyenberg, E Deak, K Pütsch, S Huenecke, C Amara, ...
haematologica 95 (4), 651, 2010
2192010
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the …
PJ Hayden, C Roddie, P Bader, GW Basak, H Bonig, C Bonini, ...
Annals of oncology 33 (3), 259-275, 2022
2172022
NK cells engineered to express a GD2‐specific antigen receptor display built‐in ADCC‐like activity against tumour cells of neuroectodermal origin
R Esser, T Müller, D Stefes, S Kloess, D Seidel, SD Gillies, ...
Journal of cellular and molecular medicine 16 (3), 569-581, 2012
1982012
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
M Stern, JR Passweg, S Meyer-Monard, R Esser, T Tonn, J Soerensen, ...
Bone marrow transplantation 48 (3), 433-438, 2013
1912013
Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors
B Anliker, T Abel, S Kneissl, J Hlavaty, A Caputi, J Brynza, IC Schneider, ...
Nature methods 7 (11), 929-935, 2010
1832010
IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation
U Koehl, J Sörensen, R Esser, S Zimmermann, HP Grüttner, T Tonn, ...
Blood Cells, Molecules, and Diseases 33 (3), 261-266, 2004
1782004
Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
M Granzin, J Wagner, U Köhl, A Cerwenka, V Huppert, E Ullrich
Frontiers in immunology 8, 458, 2017
1632017
Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus
O Beck, MS Topp, U Koehl, E Roilides, M Simitsopoulou, M Hanisch, ...
Blood 107 (6), 2562-2569, 2006
1532006
系统目前无法执行此操作,请稍后再试。
文章 1–20